Fundraising Fox

Vicora

Buffalo, US · Founded 2020 · Delaware corporation

Vicora develops a thrombectomy catheter with an integrated vibrating distal tip for removing blood clots such as those from deep vein thrombosis and pulmonary embolism. The medical device company is in pre-clinical testing and targets clinicians treating venous thromboembolism.

Founders & leadership

SPShawn Patterson
Shawn PattersonExecutive
MC
Matthew ColpoysExecutive
RD
Richard DucharmeExecutive

Board

WM
William MaggioBoard director

Reported raises · per SEC filings

Form D private placements

$3.4M disclosed across 1 round · 2025

$3.4MraisedOct 2025 · 55 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Shawn PattersonExecutive Officer
  • William MaggioDirector
  • Matthew ColpoysExecutive Officer, Director
  • Richard DucharmeExecutive Officer, Director
Offering amount
$6M
Amount sold
$3.4M
Minimum investment
$25K
First sale
Jan 2025
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 3

by search overlap

Companies competing with Vicora for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Vicora do?
Vicora develops a thrombectomy catheter with an integrated vibrating distal tip for removing blood clots such as those from deep vein thrombosis and pulmonary embolism. The medical device company is in pre-clinical testing and targets clinicians treating venous thromboembolism.
How much funding has Vicora raised?
Vicora has disclosed $3.4M raised across 1 round.
Where is Vicora headquartered?
Vicora is headquartered in Buffalo, US.